Showing 4091-4100 of 4848 results for "".
Five Ways to Turn Burnout into an Opportunity
https://practicaldermatology.com/topics/practice-management/five-ways-to-turn-burnout-into-an-opportunity/20559/A physician burnout coach offers real-life suggestions to confronting burnout.The Millennials are Coming
https://practicaldermatology.com/topics/practice-management/the-millennials-are-coming/21131/The new generation learns, interacts, and is inspired differently than a generation ago, and to stay relevant it is necessary to adapt.Encouraging Conversation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapyWhose Photos Are They, Anyway?
https://practicaldermatology.com/topics/practice-management/whose-photos-are-they-anyway/23032/An investigation of the complexities of using patient photos.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20693/Practical Considerations for Treating Psoriasis: Focus on Secukinumab
https://practicaldermatology.com/topics/psoriasis/practical-considerations-for-treating-psoriasis-focus-on-secukinumab/20841/Taking the Pulse of Device-based Aesthetics Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/taking-the-pulse-of-device-based-aesthetics-procedures/22956/With new developments in store, the evolution of devices for aesthetic procedures is creating new possibilities.Update on Oral Contraceptive Therapy in Acne
https://practicaldermatology.com/topics/general-topics/update-on-oral-contraceptive-therapy-in-acne/21582/While OCPs can be effective against acne, it is important to understand the risks and identify ideal candidates for therapy.How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.